Background
Data sharing involves making participant-level research data files available to the broader scientific community. Examples of research data that typically are involved in data sharing include survey or clinical trial data files and other experimental data that serve to support research analysis and findings. In certain fields, research data may include physical collections and bio-specimen samples (e.g., serum, plasma, DNA, and tissue) [1] . Data sharing does not refer to summary statistics, drafts of scientific papers, internal communications, laboratory notebooks, or similar items [2] .
Continued advancements in cyber infrastructure allow for more efficient data acquisition, storage, management, and integration, and provide new data-sharing opportunities. Particularly in the field of public health, data sharing promotes the translation of research findings into knowledge and practices that can further improve human health conditions [3, 4] . The benefits of data sharing are substantial and include the promotion of new research from effective use of existing data [4] [5] [6] [7] , replication of findings through re-analysis of pooled data files [7] [8] [9] , meta-analysis using individual patient data, reinforcement of open scientific inquiry [6, 10, 11] , and encouragement to develop different theoretical perspectives, especially in an interdisciplinary setting [8, 10, 12] . Data sharing adds value with little cost and thus optimizes the use of monetary and time resources [4, 8] , lessens the requirement to recruit and involve individuals in research studies since fewer studies can potentially answer a greater number of research questions [12] , and reduces the possibility that funding organizations unknowingly will 'double-fund' the same project [7] .
Numerous scientific organizations, journal editors, and research funding agencies advocate sharing data as a vital part of the scientific process [13] . Among them, the National Institutes of Health (NIH) encourage data sharing with the expectation that it will lead to products and knowledge that will benefit the public [2] . Clinical trials or studies have long been recognized as an important but costly area of research where sharing data is particularly advantageous, and sometimes vital, in order to reach scientific goals [14] . The high cost of multisite trials makes it especially important to share data for further secondary data analysis.
The National Institute on Drug Abuse (NIDA) National Drug Abuse Treatment Clinical Trials Network (CTN) is the first and the largest national network of addiction treatment researchers and community treatment programs (CTPs) working cooperatively to conduct multi-site studies of behavioral, pharmacological, and integrated treatment interventions in community-based treatment settings, with the goal of bridging between clinical research and practice [15] . In particular, the objective is to translate findings from drug-abuse treatment trials into knowledge that may be applied in the real-world treatment settings to improve treatment practices for diverse patient populations and to inform the transfer of research results to medical clinicians, other health professionals, and patients. The Data Share website (http://www.ctndatashare.org) presents an ideal platform for sharing the wealth of research data from completed CTN treatment trials, and allows for broad dissemination of study data and, ultimately, greater impact of these drug treatment studies on the addiction treatment field.
We describe the goals and development of the CTN Data Share website, from its initial inception in 2006 through its current form. From the experiences gathered throughout these years, we share and explore various lessons learned, limitations as well as major revisions of the website, and considerations for future directions for data sharing, in particular as it relates to the NIDA-CTN, but with applicability to other data-sharing initiatives.
Methods

CTN database overview and design
The CTN Data Share website was designed with several goals in mind. First, the website allows for both archiving and managing de-identified research data from completed network trials in a standard and transparent manner. Making trial data easily accessible on the Data Share website serves to increase data use and thereby to increase scientific productivity and to optimize the use of resources originally invested in the trials. The public database provides numerous opportunities for interested researchers to apply different analytic plans to stored data regarding safety and effectiveness of various interventions based on a single study or multiple studies. It also offers an opportunity for professors to use the de-identified data in their classrooms for learning and practice purposes. The Data Share website, which is linked to the larger CTN website, increases the visibility of the CTN, and attracts international collaborators as well. For example, several participants from the NIDA International Program, the INVEST Drug Abuse Research fellowship, have come to the United States to learn about clinical trials and have completed their fellowships under the mentorship of CTN investigators. These participants and the international research communities, in general, are able to use the public data to learn more about the CTN research and designs, as well as to use the collected data for additional analysis and preparation of manuscripts for publication. The CTN Data Share website also promotes analysis of pooled data files to expand knowledge about demographic and clinical characteristics of drug users who participated in the CTN studies, evaluate the quality and utility of diagnostic and clinical instruments used by multiple trials, facilitate the testing of newer hypotheses or subgroup differences in treatment responses, and generate opportunities for national and international collaboration [16] [17] [18] [19] [20] [21] [22] . Furthermore, specific advantages of analyzing cross-study data files are to increase statistical power by pooling data and, potentially, to generalize study findings to substance-use subpopulations, such as minorities [23] . Finally, the database enables the translation of research results into knowledge, products, and practice to improve public health [14] , one of the fundamental missions of the NIH.
Preparation of data for sharing
To increase timely use of data for secondary data analysis research from closed trials, the CTN's Data and Statistics Center has worked to produce the de-identified data files and release the data files and related study information to the CTN Data Share website in a timely manner, that is, either 18 months after the completion of a trial or after the primary manuscript has been accepted for publication, whichever comes first. As of July 2012, the CTN Data Share contained data files from 27 completed clinical trials (Table 1) .
Prior to posting to the website, trial data are de-identified to maintain study participant privacy, De-identified data sets for a study are prepared by staff who first critically review case report forms and the accompanying data dictionary to identify a list of variables that contain, or potentially could contain, identifying information, such as personal identifiers (e.g., names, initials), dates, free text fields, or any information that alone or in combination with other information potentially could identify a study participant. The variables then are removed or modified in a copy of the raw data set, resulting in a de-identified data set. To illustrate, all dates are replaced with days on study, where the anchor date is date of randomization, date of birth is replaced with age at randomization, site identifiers are removed, and participant study identifiers are replaced with a randomly generated numeric identifier.
De-identification of the data is a necessary step to ensure protection of participant information that is available to the public. Most data that are removed or recoded during de-identification either are not relevant to analyses so that the de-identified data remain useful for analyses; little information is lost by de-identification. For example, dates converted to days on study allow time-to-event analyses. One exception is that with individual site identifiers being removed, rather than recoded, analyses adjusting for or investigating site effects are not possible using data from the CTN Data Share website.
The CTN Data Share website is organized by protocol or study; the material specific to each study is added to the website as it becomes available. For each study, a number of important study-specific documents are also available to users of the website, are accessed separately from the data files, and therefore do not require registration to download them. For each trial on the Data Share website, the following information can be downloaded:
Data files intended to allow researchers to perform statistical analyses are available in two formats: comma-separated variable files (American Standard Code for Information Interchange (ASCII)) and Statistical Analysis System (SAS) format transport files; Descriptive metadata such as data dictionaries and annotated case report forms are provided for the data files, as well as overall descriptive data, such as study number, title, and a summary of the design; Study protocol, a document that describes the scientific rationale, objectives, design, methodology, planned analyses, and organization of the study;
De-identification notes, which describe in detail the study-specific de-identification process; Primary manuscript reference, when available; Website links external to Data Share integrated into the website to reference study summaries provided on the CTN website and the study description on clinicaltrials.gov.
In addition, taxonomy fields are provided for study keyword, investigator, and assessments associated with the study to aid in searching the Data Share website. This taxonomy, a central feature of the Data Share website, creates relationships between the various data points and links content across studies using vocabulary categorization. This classification system links data in such a way that users can find content (e.g., studies) they may not have been aware existed or were applicable to their search. For example, the first CTN study, CTN-0001 ('Buprenorphine/naloxone versus clonidine for inpatient opiate detoxification'), was assigned the following keywords: clonidine, buprenorphine, opiate, and naloxone. The principal investigator (PI) is listed for the study, as well as the seven assessments used (e.g., the Addiction Severity Index Lite). Using these entries, it is possible to see on how many other CTN studies were associated with the PI, which other studies use assessments similar to those used in CTN-0001, and which studies have been assigned similar keywords. All site content is indexed, and a robust search engine is available for users to explore the content in depth.
Administrators of the website enter data (e.g., study title, study number) directly into the website by way of data input forms with fields for each data point. Controls ensure consistency throughout the site and prevent duplication of data or minor differences such as typographical errors. A release date is listed for each study to allow for chronological sorting and filtering. Support is provided by the Data and Statistics Center to public users who send comments and questions though a link on the Data Share website. Both technical and research-oriented questions have been received; the volume of questions has been manageable so far.
Expansion of the original database
In 2011, a new feature was integrated into the CTN Data Share website to provide detailed and categorized assessment information for all studies, which allows public users to view and browse all study assessments used per study as well as identify studies that used similar assessments. This feature facilitates the identification of similar studies for pooled analyses. A listing of all study assessments can be displayed and filtered according to defined categories to display a desired subset of assessments. In addition to basic identification fields (description and abbreviation), some assessments provide an external link to one other descriptive information at the Alcohol and Drug Abuse Institute (ADAI) Library hosted on the University of Washington's website. On the CTN Data Share website, the relationships between study assessments and protocol are established, with each study assessment classified under one of nine general categories and associated subcategories as necessary ( Table 2 ). The two categories with the largest number of assessments connected with NIDA-CTN trials are 'substance use' and 'mental health', which have been further partitioned into subcategories, for example, the subcategory 'depression' within the category of 'mental health'. The full assessment list also can be filtered by category to allow displays of only those assessments that fall within a specified category, for example, 'mental health'. A decision was made to defer the categorization of assessments related to biological/physical examinations, such as vital sign and pregnancy test results and study management data, such as protocol violations and medication logs in this first phase of the project. One of the goals for future enhancement of the website is to expand the search criteria to include the latter types of assessments.
A query tool was created to allow researchers to search for specific assessments across studies, for example, to ascertain how many studies have used the Life Events Checklist, or to compare the assessments used in two or more studies, for example, to determine whether studies CTN-0001 and CTN-0019 used any of the same measures. Because the assessments are categorized into higher level substantive categories, it is also possible to search for a certain construct rather than a specific measure. For example, rather than just searching for studies that have used the Life Events Checklist, researchers can search for studies that have used any posttraumatic stress disorder (PTSD) scale. The results of the query then produce a list of studies that used similar or identical measures (e.g., Post Traumatic Stress Disorder Symptom Scale-Self Report). Furthermore, it is possible to choose any combination of measures across different categories. For example, a researcher interested in treatment of tobacco dependence with co-occurring psychiatric disorders can choose a variety of tobacco and mental health assessments to see which studies have used any or all such assessments.
Layout, technical design, and cost
To power the efficiency of search, a popular opensource content management system (CMS) was utilized and built on a standard Linux, Apache, MySQL, and PHP (LAMP) stack within a virtual and fully redundant data center. This feature provides for a powerful theming and search engine, content management, menu system, and access control, with minimal programming effort. Several custom modules also have been developed to support the assessment query and discovery features.
Each element within the website is entered via a user interface provided to appropriately privileged and trained users. Each data point is entered into a discrete form element, which ensures proper data entries and enforces field requirements (date, number, and text). When necessary, additional description or help information is provided to the user to ensure appropriate data entry. To guarantee a clean (7) Vocational Survey Pre-treatment Health perceptions and quality of life (4) EuroQol EQ-5D Clinic-related surveys (12) Treatment Program Administrator Survey Interpersonal relationships and culture (10) Family Environmental Scale Physical and general health (8) SF-36 Health Status Questionnaire Substance use (40) Tobacco, alcohol, and drugs Addiction Severity Index Sexual behavior and HIV (18) Attitudes Toward Condom Use Impulsivity and general trait and behavior scales (7) Peer Delinquency Scale Mental health (22) ADHD, antisocial personality, anxiety, dementia, depression, diagnostics, eating disorders, general/multiple disorders, PTSD, and suicidal intent
Beck depression inventory
Total: 9 categories 13 subcategories 127 assessments SF-36: Short Form 36; PTSD: posttraumatic stress disorder; ADHD: attention deficit hyperactivity disorder.
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and predictable appearance and site layout, no HTML or complex code is entered by the user. All page formatting is controlled with templates that ensure consistency and maintain a familiar look and feel to each page. Templates also facilitate the data entry process, so that minimal training is necessary for content entry. The website was developed at relatively low cost, in part due to the use of the open-source CMS. Layout and theming efforts as well as some functional programming accounted for some of the cost. A fair amount of the development effort was incurred by project staff (non-developers) to enter the study information, links, documents, and supporting metadata. Similarly, maintaining the website over time, including tasks such as the addition of studies, implementation of a query tool, and responding to users have relatively low cost. The major expenses in the implementation of the website were associated with converting the data to the Study Data Tabulation Model (SDTM) format.
CTN Data Share usage
One of the goals prompting the development of the Data Share was effective dissemination of results to the larger research community in an easy and userfriendly manner. To achieve this goal, relevant study design documents, for example, the protocol and annotated case report forms, have been made available to all public users. To understand the extent to which CTN data are downloaded (or used) by research or academic communities, potential data users are required to provide basic contact information, including the name of the investigator, his/her position, affiliation, email address, and country, before de-identified data files can be downloaded. This set of information is kept on file, but it has not been verified.
Prior to downloading the data, the potential recipient of the data is asked to review and agree to the terms and conditions for use of the data: (1) to agree not to attempt to establish the identity of any study participant; (2) to retain control of the data and not to transfer it to other entities; (3) to obtain Institutional Review Board approval of the planned research, when applicable; (4) to acknowledge the CTN in any publications or presentations; (5) to maintain security and privacy of the data; (6) to inform the NIDA Center for Clinical Trials Network (CCTN) when the research that uses the data is published; and (7) to agree that the CCTN may contact the recipient regarding the use of the data. Whenever the potential recipient of the data agrees to the terms and conditions, the applicant is asked to indicate the preferred file format. Upon completion of the web form, links to downloadable zipped files that contain the data, including study title and URL information, are made available immediately, in either ASCII or SAS format.
Another goal of the Data Share website is to encourage further analyses and promote new research. Currently, the CTN Data Share contains data files from 27 completed studies (Table 1) . Of the 27 studies, 24 were randomized controlled trials (RCTs) and 3 were surveys among clinicians and other workforces of CTPs within the NIDA-CTN. Various interventions were examined in the RCTs, of which 5 were pharmacological, 15 were psychosocial/behavioral, and 4 were combined pharmacological and psychosocial/behavioral interventions.
Results
Over a 3-year period (2010-2012), 20 requests for information were received; most took minimal effort in response. Since its inception in 2006 and through October 2012, there have been nearly 1700 downloads from the Data Share website (Figure 1) ; use has increased over the years. Individuals from 31 countries have downloaded data thus far, with the most downloads for researchers in the United States, India, and China. The number of requests for data from each specific study generally corresponds with the length of time the study data have been publicly available. Thus, the most frequently requested data set is for the first CTN study, 'Buprenorphine/naloxone versus clonidine for inpatient opiate detoxification'. To our knowledge, there are at least 13 publications in the English language derived from analyzing data through the Data Share website. Some of these involve secondary analyses of individual studies [21, [24] [25] [26] , while others have merged data from several CTN studies [22, [27] [28] [29] [30] . For example, Wu et al. applied factor and item response theory analyses to evaluate psychometric information and the quality of diagnostic tools in CTN studies [16, 17, 21, 22, 26] . The results support 
Discussion
The many findings from secondary analyses of CTN data files not only have generated timely empirical data to inform the ongoing design and conduct of addiction treatment studies and analyses of data from minorities and women to address NIH missions, but also have helped to reveal comorbidities and substance-abuse patterns of CTN participants. For example, most CTN studies require the use of diagnostic tools to apply inclusion and exclusion criteria for selection of participants. Thus, the quality of a diagnostic tool is critical to valid interpretation of study findings [16, 17, 21, 22, 26] . Women and members of minority groups often are underrepresented in clinical trials; the NIH requires the inclusion of these populations in clinical studies, unless there are appropriate reasons for excluding them from the research. The availability of data files from multiple CTN studies not only allows investigators to examine women and minority groups' ongoing participation and retention in CTN studies [31] but also helps elucidate gender and racial/ethnic issues in clinical measures, subgroup analysis, polydrug use patterns, comorbidity, and HIV risk behaviors [19, 23, 27, 28, 30, 32, 33] . These findings provide invaluable information to the addiction treatment field and inform further refinement of newer study designs [23, 34] . While the costs of maintaining the website are fairly low, the potential benefits of the use of the data are high, and continue to grow as the existing studies continue to be used and data from new studies are added to the website.
Challenges for the management of the CTN Data Share data
Making clinical research data accessible to researchers has numerous advantages. Data sharing ensures that tax payers' investment in health research has the potential to yield maximum knowledge and health benefits. The complexity of CTN Data Share lies in implementing, monitoring, and supporting existing and newer data files from ongoing studies.
One of the challenges in managing and using the Data Share website involves the minimal control exerted over data requests and usage. The initial goal for the Data Share website was to make it user friendly and accessible to encourage public usage. The procedure for requesting data files is simple, free, and quick. The requested data files are delivered immediately upon submission of a simple request form and acceptance of the terms of use. Other similar public databases may require a data requester to submit a research protocol, to obtain approval from the Institutional Review Board with which the requester is affiliated, to pay fees for the use of data, and to wait for approval [35, 36] . The disadvantage of full and easy public access is that there is little information and a lack of control regarding how the data are used; rarely are notifications received from users who have published findings utilizing the CTN data. We do not know the level of compliance with the website user agreement because compliance with the terms is not monitored or enforced. Although we do not wish to impose measures that would discourage use of the data, one initiative currently under review is to contact the researchers who have requested for data and to inquire about their compliance with the terms of the user agreement, for example, whether they have used CTN data in publications or presentations.
Another challenge in the management and use of the Data Share is related to using the legacy-converted SDTM data sets. Since 2004, the US Food and Drug Administration (FDA) has encouraged pharmaceutical industries to submit clinical trial safety data in SDTM format developed by Clinical Data Interchange Standards Consortium (CDISC; http:// www.cdisc.org/). FDA's intention is to ensure that publicly available data standards are in place. These well-defined standards are considered to support multiple uses of the data such as regulatory review, analyses across clinical research data, and exchanging data between clinical studies and electronic healthcare records, among other uses (accessed through http://www.fda.gov/Drugs/Development ApprovalProcess/FormsSubmissionRequirements/ ElectronicSubmissions/ucm269946.htm). As original CTN data were not collected with case report forms conforming to the CDISC Clinical Data Acquisition Standards Harmonization (CDASH)recommended standards, it has been difficult to ensure the accuracy of mapping from nonstandard CTN data into the SDTM format. Technical support questions received by the Data and Statistics Center and NIDA CCTN from Data Share users suggest that it is difficult to extract desired information from legacy-converted SDTM data sets. Problems associated with 'legacy data conversion' have represent the official views of the National Institutes of Health.
